Douglas, MA, United States of America

Hormoz Mazdiyashi

This inventor holds 1 USPTO granted patent. Top assignee: Aventis Pharma Deutschland, Gmbh. Active years: 2003.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Hormoz Mazdiyashi. Retrieved from https://idiyas.com/inventor/hormoz-mazdiyashi

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 8.0

ph-index = 1

Forward Citations = 20(Granted Patents)


Company Filing History:


Years Active: 2003

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Hormoz Mazdiyashi: Innovator in Pharmaceutical Chemistry

Introduction

Hormoz Mazdiyashi is a notable inventor based in Douglas, MA (US). He has made significant contributions to the field of pharmaceutical chemistry, particularly through his innovative work on substituted beta carbolines. His research and inventions have the potential to impact various therapeutic applications.

Latest Patents

Hormoz Mazdiyashi holds 1 patent related to substituted beta carbolines. This patent showcases his expertise and dedication to advancing pharmaceutical science.

Career Highlights

Mazdiyashi is currently employed at Aventis Pharma Deutschland GmbH, where he continues to develop and refine his innovative ideas. His work at this prominent pharmaceutical company allows him to collaborate with other experts in the field and contribute to groundbreaking research.

Collaborations

Hormoz has worked alongside talented colleagues such as Olaf Ritzeler and Alfredo C. Castro. These collaborations have fostered a creative environment that encourages the exchange of ideas and enhances the quality of their research.

Conclusion

Hormoz Mazdiyashi is a dedicated inventor whose work in pharmaceutical chemistry is paving the way for future innovations. His contributions, particularly in the area of substituted beta carbolines, highlight the importance of research and collaboration in advancing medical science.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…